Heme oxygenase-1 regulation of matrix metalloproteinase-1 expression underlies distinct disease profiles in tuberculosis

Journal of Immunology

Volumn 195, Issue 6, 2015, Pages 2763-2773

  Andrade, Bruno B ^a,b   Kumar, Nathella Pavan ^c,d   Amaral, Eduardo P ^a   Riteau, Nicolas ^a   Mayer Barber, Katrin D ^a   Tosh, Kevin W ^a   Maier, Nolan ^a   Conceição, Elisabete L ^b   Kubler, Andre ^e   Sridhar, Rathinam ^f   Banurekha, Vaithilingam V ^d   Jawahar, Mohideen S ^d   Barbosa, Theolis ^b   Manganiello, Vincent C ^g   Moss, Joel ^g   Fontana, Joseph R ^g   Marciano, Beatriz E ^a   Sampaio, Elizabeth P ^a   Olivier, Kenneth N ^a   Holland, Steven M ^a   Jackson, Sharon H ^h   Moayeri, Mahtab ^a   Leppla, Stephen ^a   Sereti, Irini ^a   Barber, Daniel L ^a   Nutman, Thomas B ^a   Babu, Subash ^a,c   Sher, Alan ^a   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c National Institute of Epidemiology   (India)

^d NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f Government Stanley Hospital   (India)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEME OXYGENASE 1; INTERSTITIAL COLLAGENASE; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LTBP1 PROTEIN, HUMAN; MMP1 PROTEIN, HUMAN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; BIOSYNTHESIS; BRAZIL; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; INDIA; LUNG TUBERCULOSIS; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SARCOIDOSIS; UPREGULATION; ADULT; AGED; BLOOD; FEMALE; IMMUNOLOGY; LUNG; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; UNITED STATES; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; BRAZIL; FEMALE; HEME OXYGENASE-1; HUMANS; INDIA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LATENT TGF-BETA BINDING PROTEINS; LUNG; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE STRESS; TRANSCRIPTION FACTOR AP-1; TUBERCULOSIS, PULMONARY; UNITED STATES; YOUNG ADULT;

EID: 84941771322     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500942     Document Type: Article

References (45)

1. Zumla, A., M. Raviglione, R. Hafner, and C. F. von Reyn. 2013. Tuberculosis. N. Engl. J. Med. 368: 745-755.
2. Davies, P. D., and M. Pai. 2008. The diagnosis and misdiagnosis of tuberculosis. Int. J. Tuberc. Lung Dis. 12: 1226-1234.
3. Frahm, M., N. D. Goswami, K. Owzar, E. Hecker, A. Mosher, E. Cadogan, P. Nahid, G. Ferrari, and J. E. Stout. 2011. Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb.) 91: 250-256.
4. Gopinath, K., and S. Singh. 2010. Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger? PLoS Negl. Trop. Dis. 4: e615.
5. Gupta, D., R. Agarwal, A. N. Aggarwal, and S. K. Jindal. 2012. Sarcoidosis and tuberculosis: the same disease with different manifestations or similar manifestations of different disorders. Curr. Opin. Pulm. Med. 18: 506-516.
6. Wallis, R. S., P. Kim, S. Cole, D. Hanna, B. B. Andrade, M. Maeurer, M. Schito, and A. Zumla. 2013. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect. Dis. 13: 362-372.
7. Madebo, T., B. Lindtjrn, P. Aukrust, and R. K. Berge. 2003. Circulating antioxidants and lipid peroxidation products in untreated tuberculosis patients in Ethiopia. Am. J. Clin. Nutr. 78: 117-122.
8. Palanisamy, G. S., N. M. Kirk, D. F. Ackart, C. A. Shanley, I. M. Orme, and R. J. Basaraba. 2011. Evidence for oxidative stress and defective antioxidant response in guinea pigs with tuberculosis. PLoS One 6: e26254.
9. Andrade, B. B., N. Pavan Kumar, K. D. Mayer-Barber, D. L. Barber, R. Sridhar, V. V. Rekha, M. S. Jawahar, T. B. Nutman, A. Sher, and S. Babu. 2013. Plasma heme oxygenase-1 levels distinguish latent or successfully treated human tuberculosis from active disease. PLoS One 8: e62618.
10. Pavan Kumar, N., R. Anuradha, B. B. Andrade, N. Suresh, R. Ganesh, J. Shankar, V. Kumaraswami, T. B. Nutman, and S. Babu. 2013. Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children. Clin. Vaccine Immunol. 20: 704-711.
11. Elkington, P., T. Shiomi, R. Breen, R. K. Nuttall, C. A. Ugarte-Gil, N. F. Walker, L. Saraiva, B. Pedersen, F. Mauri, M. Lipman, et al. 2011. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J. Clin. Invest. 121: 1827-1833.
12. Elkington, P. T., C. A. Ugarte-Gil, and J. S. Friedland. 2011. Matrix metalloproteinases in tuberculosis. Eur. Respir. J. 38: 456-464.
13. Sundararajan, S., S. Babu, and S. D. Das. 2012. Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients. Hum. Immunol. 73: 985-991.
14. Ugarte-Gil, C. A., P. Elkington, R. H. Gilman, J. Coronel, L. B. Tezera, A. Bernabe-Ortiz, E. Gotuzzo, J. S. Friedland, and D. A. Moore. 2013. Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis. PLoS One 8: e61333.
15. Sathyamoorthy, T., G. Sandhu, L. B. Tezera, R. Thomas, A. Singhania, C. H. Woelk, B. D. Dimitrov, D. Agranoff, C. A. Evans, J. S. Friedland, and P. T. Elkington. 2015. Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis. PLoS One 10: e0117605.
16. Elkington, P. T., R. K. Nuttall, J. J. Boyle, C. M. O'Kane, D. E. Horncastle, D. R. Edwards, and J. S. Friedland. 2005. Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am. J. Respir. Crit. Care Med. 172: 1596-1604.
17. Vincenti, M. P., and C. E. Brinckerhoff. 2002. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4: 157-164.
18. Chuang, S. M., G. Y. Liou, and J. L. Yang. 2000. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity. Carcinogenesis 21: 1491-1500.
19. Tongers, J., B. Fiedler, D. König, T. Kempf, G. Klein, J. Heineke, T. Kraft, S. Gambaryan, S. M. Lohmann, H. Drexler, and K. C. Wollert. 2004. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes. Cardiovasc. Res. 63: 545-552.
20. Zhang, M., B. H. Zhang, L. Chen, and W. An. 2002. Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation. Cell Res. 12: 123-132.
21. Griffith, D. E., T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, et al; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175: 367-416.
22. Mayer-Barber, K. D., B. B. Andrade, D. L. Barber, S. Hieny, C. G. Feng, P. Caspar, S. Oland, S. Gordon, and A. Sher. 2011. Innate and adaptive interferons suppress IL-1a and IL-1b production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35: 1023-1034.
23. Murray, P. J., J. E. Allen, S. K. Biswas, E. A. Fisher, D. W. Gilroy, S. Goerdt, S. Gordon, J. A. Hamilton, L. B. Ivashkiv, T. Lawrence, et al. 2014. Macrophage activation and polarization: nomenclature and experimental guidelines. [Published erratum appears in 2014 Immunity 41: 339-340.] Immunity 41: 14-20.
24. Bachran, C., P. K. Gupta, S. Bachran, C. E. Leysath, B. Hoover, R. J. Fattah, and S. H. Leppla. 2014. Reductive methylation and mutation of an anthrax toxin fusion protein modulates its stability and cytotoxicity. Sci. Rep. 4: 4754.
25. Pomerantsev, A. P., O. M. Pomerantseva, M. Moayeri, R. Fattah, C. Tallant, and S. H. Leppla. 2011. A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins. Protein Expr. Purif. 80: 80-90.
26. Liu, S., H. J. Leung, and S. H. Leppla. 2007. Characterization of the interaction between anthrax toxin and its cellular receptors. Cell. Microbiol. 9: 977-987.
27. Shiloh, M. U., P. Manzanillo, and J. S. Cox. 2008. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3: 323-330.
28. Kumar, R., P. Halder, S. K. Sahu, M. Kumar, M. Kumari, K. Jana, Z. Ghosh, P. Sharma, M. Kundu, and J. Basu. 2012. Identification of a novel role of ESAT-6-dependent miR-155 induction during infection of macrophages with Mycobacterium tuberculosis. Cell. Microbiol. 14: 1620-1631.
29. Abdalla, H., L. Srinivasan, S. Shah, K. D. Mayer-Barber, A. Sher, F. S. Sutterwala, and V. Briken. 2012. Mycobacterium tuberculosis infection of dendritic cells leads to partially caspase-1/11-independent IL-1b and IL-18 secretion but not to pyroptosis. PLoS One 7: e40722.
30. Green, J. A., P. T. Elkington, C. J. Pennington, F. Roncaroli, S. Dholakia, R. C. Moores, A. Bullen, J. C. Porter, D. Agranoff, D. R. Edwards, and J. S. Friedland. 2010. Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks. J. Immunol. 184: 6492-6503.
31. Rousset, F., M. V. Nguyen, L. Grange, F. Morel, and B. Lardy. 2013. Heme oxygenase-1 regulates matrix metalloproteinase MMP-1 secretion and chondrocyte cell death via Nox4 NADPH oxidase activity in chondrocytes. PLoS One 8: e66478.
32. Desmard, M., K. S. Davidge, O. Bouvet, D. Morin, D. Roux, R. Foresti, J. D. Ricard, E. Denamur, R. K. Poole, P. Montravers, et al. 2009. A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J. 23: 1023-1031.
33. Nobre, L. S., F. Al-Shahrour, J. Dopazo, and L. M. Saraiva. 2009. Exploring the antimicrobial action of a carbon monoxide-releasing compound through wholegenome transcription profiling of Escherichia coli. Microbiology 155: 813-824.
34. Zacharia, V. M., and M. U. Shiloh. 2012. Effect of carbon monoxide on Mycobacterium tuberculosis pathogenesis. Med. Gas Res. 2: 30.
35. Kumar, A., J. S. Deshane, D. K. Crossman, S. Bolisetty, B. S. Yan, I. Kramnik, A. Agarwal, and A. J. Steyn. 2008. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J. Biol. Chem. 283: 18032-18039.
36. Zacharia, V. M., P. S. Manzanillo, V. R. Nair, D. K. Marciano, L. N. Kinch, N. V. Grishin, J. S. Cox, and M. U. Shiloh. 2013. cor, a novel carbon monoxide resistance gene, is essential for Mycobacterium tuberculosis pathogenesis. MBio 4: e00721-e13.
37. Ong, C. W., P. T. Elkington, and J. S. Friedland. 2014. Tuberculosis, pulmonary cavitation, and matrix metalloproteinases. Am. J. Respir. Crit. Care Med. 190: 9-18.
38. Exner, M., E. Minar, O. Wagner, and M. Schillinger. 2004. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic. Biol. Med. 37: 1097-1104.
39. Ganachari, M., J. A. Ruiz-Morales, J. C. Gomez de la Torre Pretell, J. Dinh, J. Granados, and P. O. Flores-Villanueva. 2010. Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals. PLoS One 5: e8881.
40. Hsieh, M. H., P. C. Chou, C. L. Chou, S. C. Ho, W. C. Joa, L. F. Chen, T. F. Sheng, H. C. Lin, T. Y. Wang, P. J. Chang, et al. 2013. Matrix metalloproteinase-1 polymorphism (-1607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan. PLoS One 8: e66265.
41. Mendonca, V. R., N. F. Luz, N. J. Santos, V. M. Borges, M. S. Goncalves, B. B. Andrade, and M. Barral-Netto. 2012. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect. Immun. 80: 1445-1454.
42. Ninomiya, S., T. Niimi, S. Shimizu, S. Sato, H. Achiwa, H. Ito, K. Akita, H. Maeda, and R. Ueda. 2004. Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc. Diffuse Lung Dis. 21: 19-24.
43. Saukkonen, K., P. Lakkisto, M. A. Kaunisto, M. Varpula, L. M. Voipio-Pulkki, T. Varpula, V. Pettilä, and K. Pulkki. 2010. Heme oxygenase 1 polymorphisms and plasma concentrations in critically ill patients. Shock 34: 558-564.
44. Sheu, C. C., R. Zhai, Z. Wang, M. N. Gong, P. Tejera, F. Chen, L. Su, B. T. Thompson, and D. C. Christiani. 2009. Heme oxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome. Intensive Care Med. 35: 1343-1351.
45. Sri Manjari, K., P. Nallari, N. Balakrishna, A. Vidyasagar, B. Prabhakar, A. Jyothy, and A. Venkateshwari. 2013. Influence of matrix metalloproteinase-1 gene -1607 (1G/2G) (rs1799750) promoter polymorphism on circulating levels of MMP-1 in chronic pancreatitis. Biochem. Genet. 51: 644-654.